The department of science and innovation says the state-backed vaccine developer Biovac has met its expectations, despite the fact that it has yet to manufacture any of its own shots more than 15 years after its inception.

Biovac is a public-private partnership that was established in 2003 to revive SA’s human vaccine manufacturing capacity. Earlier this week, it emerged that the health department is running a new tender that threatens Biovac’s income, raising questions about how the government sees the future of this venture...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.